|
Production of recombinant vaccines for Mycoplasma gallisepticum, Mycoplasma synoviae
|
Prof. Dr.Sabry Esmaeil
|
2 Year
|
|
toxoplasmosis: Insights from the One Health Initiative into Genetic Characterization, Vaccination and Therapies
|
Dr. Dalia Mustafa Al-Husseini
|
2 Year
|
|
Nanotechnology based diagnostic tool production for lumpy skin disease virus (LSDV) diagnosis in vitro
|
Dr. Samar Hamdi Qasim
|
3 Year
|
|
Green nanocomposite of bee pollen chitosan as multifunctional activities against multidrug resistance of microorganisms in farm animals
|
Dr. Dalia Al Masry
|
3 Year
|
|
Application of cell-free protein synthesis systems in development of novel viral vaccine production
|
Dr. Mohammed Hassan Abdullah Al-Hussaini
|
2 Year
|
|
Development of a one-step real-time RT-PCR kit for detection of SARS-COV2 virus
|
Prof. Dr. Abdul Sattar Arfa
|
1 Year
|
|
Development of antigen-based ELISA kits for the simultaneous diagnosis of Mycoplasma gallisepticum, Mycoplasma synoviae and M. meleagridis in chickens and turkeys
|
Prof. Dr. Abdel Wahid Mahmoud Hassan
|
2 Year
|
|
Production of a new diagnostic test for the diagnosis of bovine tuberculosis
|
Dr. Iman Mahrous Abdel Ghani
|
2 Year
|
|
Phenotypic and genetic diagnosis of abortive bacteria in Arabian horses causing abortion in horses with attention to antibiotic resistance genes
|
Dr. Shaimaa Ramadan Abdel Mawgoud
|
3 Year
|
|
the development of an Egyptian vaccine against SARS-CoV-2 DNA
|
Dr. Mahmoud Samir
|
1 Year
|
